Search results

Skip to results

Type

Type

Last updated

Last updated

Advice programme

Showing 1 to 3 of 3 results for amphotericin

  1. What are the clinical and cost effectiveness, and the safety, of specific antifungal treatments for treating suspected or confirmed COVID-19-associated pulmonary aspergillosis (CAPA), and the optimal treatment duration? When should treatment be started, stopped or modified?

    isavuconazole, liposomal amphotericin B, posaconazole, echinocandins (for example, caspofungin, anidulafungin) and...

    Research recommendation
    Published
    9 March 2022

  2. Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate (ESUOM4)

    Summary of the evidence on oral magnesium glycerophosphate for preventing recurrent hypomagnesaemia to inform local NHS planning and decision-making

    Evidence summary
    Published
    29 January 2013

  3. Fungitell for antifungal treatment stratification (MIB118)

    NICE has developed a medtech innovation briefing (MIB) on Fungitell for antifungal treatment stratification .

    Medtech innovation briefing
    Published
    31 August 2017